Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.350
+0.150 (12.50%)
At close: Aug 13, 2025, 4:00 PM
1.349
-0.001 (-0.10%)
After-hours: Aug 13, 2025, 7:26 PM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $60.58 million as of August 13, 2025. Its market cap has decreased by -48.94% in one year.
Market Cap
60.58M
Enterprise Value
-1.18M
1-Year Change
-48.94%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $60.58M, a decrease of -86.24%. That is a compound annual growth rate of -37.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 53.85M | -18.35% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |